The MEDICREA Group: 2009 Half Year Results

Share this story with your network

LYON, France–(BUSINESS WIRE)–The MEDICREA Group (Paris: ALMED), listed on Alternext by NYSE – Euronext Paris, a specialist in the design, manufacture and sale of spinal implants, is publishing its 2009 half year results.

HALF YEAR RESULTS IN LINE WITH THE GROUP’S STRATEGY OF STRONG GROWTH

  • Sales of €6.1 million at June 30, 2009, up 32%
  • Recovery in gross margin
  • Bolstered commercial marketing and clinical studies investments, especially in the USA

H1 2009 RESULTS AND SALIENT FACTS

In € millions H1 2008 H2 2008 H1 2009 (1)

Net sales

Gross margin in %

Operating income

EBITDA (2)

Pretax income from ordinary activities

Income before goodwill amortization

Net income

4,6

68 %

(1,7)

(0,9)

(1,7)

(1,2)

(1,5)

4,4

51 %

(2,2)

(1,6)

(2,4)

(3,2)

(3,4)

6,1

64 %

(1,5)

(0,8)

(1,7)

(1,2)

(1,5)

(1) : Non audited half year accounts – French GAAP
(2) : EBITDA : Earnings before Interests, taxes, depreciation and amortization

Leave a Comment

Your email address will not be published. Required fields are marked *

*